While omega-3 supplements play a key role in human health, GOED did not find sufficient data to link intake of EPA and DHA omega-3s to “general” to “viral” immunity benefits.
Photo © iStockphoto.com/Matt_Brown
In response to the COVID-19 pandemic and confusion about the role omega-3s may play in immunity-based protection, the Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City) issued an industry advisory on the topic. After searching a proprietary clinical study database of all human studies on omega-3s, GOED has concluded that the current science does not support a claim. While omega-3 supplements play a key role in human health, GOED did not find sufficient data to link intake of EPA and DHA omega-3s to “general” to “viral” immunity benefits and GOED urges the industry to act responsibly in its marketing.
Additionally, FDA and FTC are closely watching for misleading product claims around COVID-19 prevention or treatment, and GOED believes even a general “immunity” claim on a product could be considered an implied claim about COVID-19 given the current environment.
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.